Related Experiment Video
Updated: Jun 11, 2025
06:53
Use of Primary Cultured Hippocampal Neurons to Study the Assembly of Axon Initial Segments
Published on: February 12, 2021
5.0K
Impaired axon initial segment structure and function in a model of ARHGEF9 developmental and epileptic encephalopathy
Wanqi Wang1,2, Damian J Williams1,3, Jia Jie Teoh1,4
1Department of Neurology, Center for Translational Research in Neurodevelopmental Disease, Columbia University Irving Medical Center, New York, NY 10032.
Summary
Genetic variants in ARHGEF9 cause severe developmental and epileptic encephalopathies (DEE) by disrupting inhibitory synapses at the axon initial segment (AIS). This study reveals ARHGEF9’s role in AIS structure and function, offering insights into DEE pathology.
Area of Science:
- Neuroscience
- Genetics
- Epilepsy Research
Background:
- Developmental and epileptic encephalopathies (DEE) are severe childhood epilepsies with limited treatment options.
- Genetic variants in ARHGEF9 are linked to DEE and complex neurological symptoms.
- ARHGEF9 is crucial for organizing inhibitory synapses.
Purpose of the Study:
- To investigate the pathological mechanisms of ARHGEF9 variants in DEE.
- To examine the impact of a patient-derived ARHGEF9 variant on synaptic function and neuronal excitability in a mouse model.
Main Methods:
- Utilized a mouse model with a patient-derived ARHGEF9 variant.
- Analyzed postsynaptic protein aggregation and inhibitory synapse function at the axon initial segment (AIS).
- Assessed axo-axonic synaptic inhibition and action potential generation.
Main Results:
- Observed postsynaptic protein aggregation and loss of functional inhibitory synapses at the AIS.
- Found altered axo-axonic synaptic inhibition and disrupted action potential generation.
- Documented complex seizure phenotypes mirroring clinical observations in ARHGEF9-associated DEE.
Conclusions:
- ARHGEF9 plays a critical role in regulating the structure and function of the AIS.
- Dysfunction of ARHGEF9 leads to multiple AIS abnormalities, contributing to DEE pathogenesis.
- This research provides a novel pathological mechanism for ARHGEF9-associated DEE and may guide therapeutic strategies for neurodevelopmental disorders.
